DAVID SULLIVAN, M.D.
Osteopathic Medicine at Wolfe St, Baltimore, MD

License number
Maryland D52722
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-1725

Personal information

See more information about DAVID SULLIVAN at radaris.com
Name
Address
Phone
David Sullivan
5019 Wyandot Ct, Bethesda, MD 20816

Organization information

See more information about DAVID SULLIVAN at bizstanding.com

David Sullivan MD

600 N Wolfe St, Baltimore, MD 21287

Industry:
Internist
Phone:
(410) 955-1725 (Phone)
David Joseph Sullivan Jr

Professional information

David Sullivan Photo 1

David Sullivan - Baltimore, MD

Work:
Capital One Financial - Las Vegas, NV
Risk Senior Representative
Clearwire - Las Vegas, NV
Technical Support Representative
Comcast - Livermore, CA
Programming & Technical support
Cablevision - CSR - Newark, NJ
Sales and Management
Purity Dairies - Nashville, TN
Admin Assistant
Lanter /OHL - Nashville, TN
Asst Crew Mgr
BarnesandNoble.com - Secaucus, NJ
Assisting customers
Primerica - Union, NJ
Sales Rep
Education:
University of Phoenix - Las Vegas, NV
Communications
Jacksonville St Univ - Jacksonville, AL
Psychology
Blazer Business Institute - Clark, NJ
Insurance
Montclair High School - Montclair, NJ
Diploma
Skills:
collections, sales and customer service


David Sullivan Photo 2

Dr. David Sullivan, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
615 N Wolfe St SUITE E5628, Baltimore 21205
(410) 614-1562 (Phone), (410) 955-0105 (Fax)
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
Certifications:
Infectious Disease, 1994, Internal Medicine, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
615 N Wolfe St SUITE E5628, Baltimore 21205
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
University of Alabama At Birmingham
Graduated: 1988
Barnes-Jewish Hospital


David Sullivan Photo 3

Student At University Of Maryland University College

Location:
Baltimore, Maryland Area
Industry:
Health, Wellness and Fitness
Education:
University of Maryland University College 2008 - 2010


David Sullivan Photo 4

Student At Oakwood College

Location:
Baltimore, Maryland Area
Industry:
Music
Work:
Navillus & Co. Apr 2008 - May 2010 - CEO
Education:
Oakwood College 2007 - 2011


David Sullivan Photo 5

Loan Processor At 1St Chesapeake Home Mortgage

Position:
Loan Processor at 1st Chesapeake Home Mortgage
Location:
Baltimore, Maryland Area
Industry:
Banking
Work:
1st Chesapeake Home Mortgage - Loan Processor


David Sullivan Photo 6

David Sullivan

Location:
Baltimore, Maryland Area
Industry:
Real Estate


David Sullivan Photo 7

Detection Of Malaria Parasites By Mass Spectrometry

US Patent:
2005004, Feb 24, 2005
Filed:
Mar 28, 2003
Appl. No.:
10/502834
Inventors:
Plamen Demirev - Ellicott City MD, US
Andrew Feldman - Columbia MD, US
Nirbhay Kumar - Bethesda MD, US
Peter Scholl - Baltimore MD, US
David Sullivan - Baltimore MD, US
International Classification:
G01N033/53, G01N033/569
US Classification:
435007220
Abstract:
Mass spectrometric techniques are provided for detecting the presence of parasites that accumulate unbound heme in red blood cells (including malaria parasites), based on the discovery that unbound heme can be detected and quantified using mass spectrometry. In one aspect of the invention, the method includes the steps of: obtaining a blood sample from the animal; preparing a test sample on a support from the blood sample, and inserting the support into a mass spectrometer for analysis. Next one obtains a mass spectrum of the test sample and determines whether the mass spectrum contains a mass/charge signature of unbound heme. If it is determined that the mass spectrum of the test sample shows the mass/charge signature of unbound heme, the animal is diagnosed as infected with malaria parasites.


David Sullivan Photo 8

Mehods And Compositions For Inhibiting Impdh-1 Isoform 1

US Patent:
2010033, Dec 30, 2010
Filed:
Mar 20, 2007
Appl. No.:
12/225391
Inventors:
Jun O. Liu - Clarksville MD, US
Curtis Robert Chong - Honolulu HI, US
David J. Sullivan - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61M 31/00, A61K 38/50, A61K 31/7052, A61K 31/4174, A61K 31/496, A61K 31/4196, A61K 31/506, A61K 31/7072, A61K 31/58, A61P 35/00, A61P 17/00, A61P 7/10, A61P 19/02, A61P 29/00, A61P 3/00
US Classification:
424427, 424 946, 514 43, 514396, 514399, 51425407, 514383, 514256, 514 50, 514176
Abstract:
Described herein are methods of inhibiting IMPDH type 1, and treating or preventing a disease or disorder (or symptoms thereof) associated with IMPDH type 1, wherein an IMPDH type 1 inhibitor compound is administered to a subject.


David Sullivan Photo 9

Plasmodium Diagnostic Assay Device

US Patent:
2009011, May 7, 2009
Filed:
Jan 25, 2006
Appl. No.:
11/883130
Inventors:
David J. Sullivan - Baltimore MD, US
Peter Scholl - Baltimore MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
C12Q 1/44, C12Q 1/02, C12Q 1/32, C12M 1/00
US Classification:
435 19, 435 29, 435 26, 4352871
Abstract:
This invention relates to assays for a analyte in a liquid sample such as a body fluid. More particularly, the invention relates to a method and apparatus for the detection of a ligand in a body fluid such as urine or blood, which can diagnose malarial infection.


David Sullivan Photo 10

Angiogenesis Inhibitors

US Patent:
2008019, Aug 14, 2008
Filed:
Jun 27, 2005
Appl. No.:
11/630596
Inventors:
Jun Liu - Clarksville MD, US
Curtis Chong - Baltimore MD, US
David J. Sullivan - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61F 2/00, A61K 31/513, A61K 31/343, A61K 31/58, A61K 31/4196, A61K 31/506, A61K 9/00, A61K 38/50, A61K 31/496
US Classification:
424423, 514274, 514470, 514176, 424 946, 51425407, 424484, 514383, 514256
Abstract:
Described herein are methods of inhibiting angiogenesis, and treating or preventing a disease or disorder (or symptoms thereof) associated with angiogenesis, wherein an anti-angiogenesis compound is administered to a subject.